234 related articles for article (PubMed ID: 7587786)
21. Subcellular kinetics of early trypsinogen activation in acute rodent pancreatitis.
Mithöfer K; Fernández-del Castillo C; Rattner D; Warshaw AL
Am J Physiol; 1998 Jan; 274(1):G71-9. PubMed ID: 9458775
[TBL] [Abstract][Full Text] [Related]
22. Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications.
Hotz HG; Foitzik T; Rohweder J; Schulzke JD; Fromm M; Runkel NS; Buhr HJ
J Gastrointest Surg; 1998; 2(6):518-25. PubMed ID: 10458730
[TBL] [Abstract][Full Text] [Related]
23. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates.
Schmidt J; Fernández-del Castillo C; Rattner DW; Lewandrowski K; Compton CC; Warshaw AL
Gastroenterology; 1992 Sep; 103(3):1009-16. PubMed ID: 1499902
[TBL] [Abstract][Full Text] [Related]
24. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
25. Endothelin mediates local and systemic disease sequelae in severe experimental pancreatitis.
Foitzik T; Faulhaber J; Hotz HG; Kirchengast M; Buhr HJ
Pancreas; 2001 Apr; 22(3):248-54. PubMed ID: 11291925
[TBL] [Abstract][Full Text] [Related]
26. Mechanism and role of trypsinogen activation in acute pancreatitis.
Mayer J; Rau B; Schoenberg MH; Beger HG
Hepatogastroenterology; 1999; 46(29):2757-63. PubMed ID: 10576341
[TBL] [Abstract][Full Text] [Related]
27. Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.
Foitzik T; Forgacs B; Ryschich E; Hotz H; Gebhardt MM; Buhr HJ; Klar E
Transplantation; 1998 Apr; 65(8):1030-6. PubMed ID: 9583861
[TBL] [Abstract][Full Text] [Related]
28. Intravenous contrast medium impairs oxygenation of the pancreas in acute necrotizing pancreatitis in the rat.
Foitzik T; Bassi DG; Fernández-del Castillo C; Warshaw AL; Rattner DW
Arch Surg; 1994 Jul; 129(7):706-11. PubMed ID: 8024450
[TBL] [Abstract][Full Text] [Related]
29. Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis.
Schmidt J; Ferńandez-del Castillo C; Rattner DW; Lewandrowski KB; Messmer K; Warshaw AL
Am J Surg; 1993 Jan; 165(1):40-4; discussion 45. PubMed ID: 7678189
[TBL] [Abstract][Full Text] [Related]
30. Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic injury in necrotizing pancreatitis of the rat.
Schmidt J; Ryschich E; Sinn HP; Maksan S; Herfarth C; Klar E
Dig Dis Sci; 1999 Apr; 44(4):823-9. PubMed ID: 10219844
[TBL] [Abstract][Full Text] [Related]
31. Rho-kinase signalling regulates trypsinogen activation and tissue damage in severe acute pancreatitis.
Awla D; Hartman H; Abdulla A; Zhang S; Rahman M; Regnér S; Thorlacius H
Br J Pharmacol; 2011 Feb; 162(3):648-58. PubMed ID: 20942858
[TBL] [Abstract][Full Text] [Related]
32. Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis.
Grady T; Saluja A; Kaiser A; Steer M
Am J Physiol; 1996 Jul; 271(1 Pt 1):G20-6. PubMed ID: 8760102
[TBL] [Abstract][Full Text] [Related]
33. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.
Foitzik T; Faulhaber J; Hotz HG; Kirchengast M; Buhr HJ
Ann Surg; 1998 Nov; 228(5):670-5. PubMed ID: 9833805
[TBL] [Abstract][Full Text] [Related]
34. Effect of buprenorphine on pancreatic enzyme synthesis and secretion in normal rats and rats with acute edematous pancreatitis.
Ogden JM; Modlin IM; Gorelick FS; Marks IN
Dig Dis Sci; 1994 Nov; 39(11):2407-15. PubMed ID: 7525167
[TBL] [Abstract][Full Text] [Related]
35. Local and systemic zymogen activation in human acute pancreatitis.
Mayer JM; Rau B; Siech M; Beger HG
Digestion; 2000; 62(2-3):164-70. PubMed ID: 11025364
[TBL] [Abstract][Full Text] [Related]
36. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis.
Foitzik T; Lewandrowski KB; Fernández-del Castillo C; Rattner DW; Warshaw AL
Surgery; 1994 Jun; 115(6):698-702. PubMed ID: 8197561
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopexamine on acute necrotising pancreatitis in rats.
Alhan E; Küçüktülü U; Erçin C; Deger O; Cicek R
Eur J Surg; 2001 Oct; 167(10):761-6. PubMed ID: 11775728
[TBL] [Abstract][Full Text] [Related]
38. Hyperbaric oxygen therapy attenuates pancreatic microcirculatory derangement and lung edema in an acute experimental pancreatitis model in rats.
Chen HM; Shyr MH; Ueng SW; Chen MF
Pancreas; 1998 Jul; 17(1):44-9. PubMed ID: 9667519
[TBL] [Abstract][Full Text] [Related]
39. The effects of prostaglandin E1 on the microperfusion of the pancreas during acute necrotizing pancreatitis in rats.
Yücel K; Alhan E; Küçüktülü U; Piri M; Erçin C; Deger O
Hepatogastroenterology; 2002; 49(44):544-8. PubMed ID: 11995492
[TBL] [Abstract][Full Text] [Related]
40. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis.
Foitzik T; Mithöfer K; Ferraro MJ; Fernández-del Castillo C; Lewandrowski KB; Rattner DW; Warshaw AL
Ann Surg; 1994 Aug; 220(2):193-8. PubMed ID: 8053741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
